This suppression of the RAD21 gene also enhanced the cytotoxicity of etoposide and bleomycin (two DNA-damaging chemotherapeutic agents), which revealed that by the induction of DNA damage, RAD21 can be a novel target for developing cancer therapeutics [34]. The gene discussed is RAD21; the disease is cancer.